{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"ISRCTN","place":["London, UK"]}],"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T15:44:36Z","timestamp":1746805476646,"version":"3.40.5"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1186\/isrctn60043317","type":"dataset","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T01:05:13Z","timestamp":1620090313000},"source":"Crossref","is-referenced-by-count":0,"title":["A study to investigate the absorption, metabolism, excretion, and bioavailability of oral and intravenous inavolisib in healthy volunteers"],"prefix":"10.1186","author":[{"given":"Clinical","family":"Trials","sequence":"first","affiliation":[]}],"member":"297","content-created":{"date-parts":[[2021,5,4]]},"container-title":["http:\/\/isrctn.com\/"],"original-title":[],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T01:05:14Z","timestamp":1620090314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.isrctn.com\/ISRCTN60043317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1186\/isrctn60043317","relation":{},"subject":[],"published":{"date-parts":[[2021,5,4]]}}}